Literature DB >> 18566985

The burden of silicosis, pulmonary tuberculosis and COPD among former Basotho goldminers.

Brendan V Girdler-Brown1, Neil W White, Rodney I Ehrlich, Gavin J Churchyard.   

Abstract

BACKGROUND: The burden of silicosis, pulmonary tuberculosis and COPD is described in 624 South African gold miners 18 months after cessation of work.
METHODS: This was a prevalence study. Questionnaires were administered, and spirometry, chest radiography, tuberculosis investigations, and urine HIV antibody assays were performed.
RESULTS: Attendance was 80.1% (624/779), mean age 49.4 years, and mean employment duration 25.6 years. Most subjects had had medium (26.5%) or high (65.4%) dust-exposure jobs. Current smoking rate was 35%, with ever smoking 61%. HIV antibodies were detected in the urine in 22.3%. Prevalences were: silicosis 24.6%, past tuberculosis 26%, current tuberculosis 6.2%, airflow obstruction 13.4%, and chronic productive cough 17.7%. Almost 50% of these miners had at least one of these respiratory conditions.
CONCLUSIONS: A heavy burden of silicosis, tuberculosis and COPD was present in this group of former goldminers. Intensification of work place dust control measures and TB and HIV prevention activities are needed on South African gold mines. In labor sending communities investment is needed in silicosis and tuberculosis surveillance as well as HIV treatment and care. Published 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566985     DOI: 10.1002/ajim.20602

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  24 in total

1.  [Hemoptysis in a patient with severe COPD and silicosis].

Authors:  K E Sander; C-M Sommer; M Andrulis; P Reimer; M Kreuter; F J F Herth; C P Heußel
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-03-16       Impact factor: 0.840

Review 2.  A Review of Research on Health Outcomes for Workers, Home and Host Communities of Population Mobility Associated with Extractive Industries.

Authors:  Jason G Carney; Brian D Gushulak
Journal:  J Immigr Minor Health       Date:  2016-06

Review 3.  Epidemiology of tuberculosis and HIV: recent advances in understanding and responses.

Authors:  Neil A Martinson; Christopher J Hoffmann; Richard E Chaisson
Journal:  Proc Am Thorac Soc       Date:  2011-06

4.  Three decades of silicosis: disease trends at autopsy in South African gold miners.

Authors:  Gill Nelson; Brendan Girdler-Brown; Ntombizodwa Ndlovu; Jill Murray
Journal:  Environ Health Perspect       Date:  2010-03       Impact factor: 9.031

5.  Mining: South Africa's legacy and burden in the context of occupational respiratory diseases.

Authors:  Rajen N Naidoo
Journal:  Glob Health Action       Date:  2013-02-21       Impact factor: 2.640

Review 6.  Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis.

Authors:  Katharina Kranzer; Rein Mgj Houben; Judith R Glynn; Linda-Gail Bekker; Robin Wood; Stephen D Lawn
Journal:  Lancet Infect Dis       Date:  2010-02       Impact factor: 25.071

7.  The risk of pulmonary tuberculosis in underground copper miners in Zambia exposed to respirable silica: a cross-sectional study.

Authors:  Kingsley Ngosa; Rajen N Naidoo
Journal:  BMC Public Health       Date:  2016-08-23       Impact factor: 3.295

8.  The production of consumption: addressing the impact of mineral mining on tuberculosis in southern Africa.

Authors:  Sanjay Basu; David Stuckler; Gregg Gonsalves; Mark Lurie
Journal:  Global Health       Date:  2009-09-29       Impact factor: 4.185

9.  "Even if I were to consent, my family will never agree": exploring autopsy services for posthumous occupational lung disease compensation among mineworkers in South Africa.

Authors:  Audrey V Banyini; David Rees; Leah Gilbert
Journal:  Glob Health Action       Date:  2013-01-24       Impact factor: 2.640

10.  Occupational respiratory diseases in the South African mining industry.

Authors:  Gill Nelson
Journal:  Glob Health Action       Date:  2013-01-24       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.